We are live on ! Find out more
Neuberger Berman Group

Neuberger Berman Group Portfolio holdings

AUM $131B
1-Year Est. Return 28.36%
This Fund
S&P 500
This Quarter Est. Return
+8.07%
1 Year Est. Return
+28.36%
3 Year Est. Return
+86.21%
5 Year Est. Return
+112.87%
10 Year Est. Return
+467.9%
AUM
$128B
AUM Growth
+$6.33B
Cap. Flow
-$1.51B
Cap. Flow %
-1.18%
Top 10 Hldgs %
19.21%
Holding
2,027
New
130
Increased
837
Reduced
887
Closed
100

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$424M
2
MDLZ icon
Mondelez International
MDLZ
+$251M
3
PG icon
Procter & Gamble
PG
+$233M
4
CSX icon
CSX Corp
CSX
+$184M
5
PGR icon
Progressive
PGR
+$183M

Sector Composition

Rank Sector Weight
1 Technology 26.07%
2 Financials 13.36%
3 Industrials 11.95%
4 Healthcare 11.14%
5 Consumer Discretionary 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UVSP icon
901
Univest Financial
UVSP
$1.23B
$5.98M ﹤0.01%
212,513
-25,631
-11% -$683K
VALU icon
902
Value Line
VALU
$342M
$5.98M ﹤0.01%
128,596
-3,601
-3% -$158K
UMH
903
UMH Properties
UMH
$1.3B
$5.96M ﹤0.01%
302,903
+9,054
+3% +$168K
AGNC icon
904
AGNC Investment
AGNC
$12.6B
$5.95M ﹤0.01%
568,367
-37,591
-6% -$382K
ASND icon
905
Ascendis Pharma A/S
ASND
$16B
$5.94M ﹤0.01%
39,762
+9,466
+31% +$1.28M
BPMC
906
DELISTED
Blueprint Medicines
BPMC
$5.91M ﹤0.01%
63,879
+10,110
+19% +$1M
RNR icon
907
RenaissanceRe
RNR
$13.4B
$5.88M ﹤0.01%
21,597
+15
+0.1% +$3.62K
MRNA icon
908
Moderna
MRNA
$22B
$5.85M ﹤0.01%
87,501
-167,320
-66% -$15.4M
BR icon
909
Broadridge
BR
$18.2B
$5.76M ﹤0.01%
26,782
+11,835
+79% +$2.48M
EE icon
910
Excelerate Energy
EE
$1.24B
$5.76M ﹤0.01%
261,636
+32,990
+14% +$639K
CSGP icon
911
CoStar Group
CSGP
$12.2B
$5.73M ﹤0.01%
76,013
-7,541
-9% -$572K
OC icon
912
Owens Corning
OC
$11.5B
$5.69M ﹤0.01%
32,233
-5,475
-15% -$922K
IOT icon
913
Samsara
IOT
$21.6B
$5.67M ﹤0.01%
117,769
-75,339
-39% -$3.05M
UBS icon
914
UBS Group
UBS
$173B
$5.65M ﹤0.01%
182,859
-513,717
-74% -$15.4M
CCJ icon
915
Cameco
CCJ
$39.1B
$5.65M ﹤0.01%
118,217
+13,280
+13% +$579K
YUMC icon
916
Yum China
YUMC
$16.6B
$5.59M ﹤0.01%
118,410
+82,650
+231% +$2.75M
CPRT icon
917
Copart
CPRT
$27.2B
$5.58M ﹤0.01%
106,436
+32,173
+43% +$1.67M
CCK icon
918
Crown Holdings
CCK
$13B
$5.55M ﹤0.01%
57,895
+183
+0.3% +$15.8K
FTNT icon
919
Fortinet
FTNT
$120B
$5.51M ﹤0.01%
71,013
+303
+0.4% +$20.7K
STM icon
920
STMicroelectronics
STM
$46.5B
$5.47M ﹤0.01%
184,065
+30,913
+20% +$1.02M
FSK icon
921
FS KKR Capital
FSK
$3.11B
$5.46M ﹤0.01%
276,498
-22,117
-7% -$439K
EPAM icon
922
EPAM Systems
EPAM
$5.6B
$5.44M ﹤0.01%
27,313
+282
+1% +$56.5K
CTRE icon
923
CareTrust REIT
CTRE
$9.74B
$5.41M ﹤0.01%
175,248
+2,195
+1% +$62.1K
CORT icon
924
Corcept Therapeutics
CORT
$12.2B
$5.38M ﹤0.01%
+116,337
New +$4.13M
SGC icon
925
Superior Group of Companies
SGC
$202M
$5.34M ﹤0.01%
344,516
-36,949
-10% -$602K

Similar funds

Neuberger Berman Group's Q3 2024 Portfolio in Review

As of Q3 2024, Neuberger Berman Group held 2,027 positions worth $128B, up 5.2% from $122B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Neuberger Berman Group's Q3 2024 filing shows 130 new, 837 increased, 887 reduced and 100 closed positions. Its largest new stake was Neuberger Core Equity ETF: 8,609,942 shares worth $228M. The largest sale was Merck, an estimated $424M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.

  • Neuberger Berman Group's largest Q3 2024 buy was Neuberger Core Equity ETF: 8,609,942 shares worth $228M.
  • Neuberger Berman Group added most to UnitedHealth in Q3 2024, an estimated $233M increase.
  • Neuberger Berman Group's biggest Q3 2024 reduction was Merck, cutting an estimated $424M.
  • Neuberger Berman Group fully exited Simulations Plus in Q3 2024, selling an estimated $61.8M.
  • Neuberger Berman Group's ten largest holdings make up 19% of its $128B portfolio in Q3 2024.
  • Neuberger Berman Group opened 130 new positions and closed 100 in Q3 2024.
  • Neuberger Berman Group's portfolio value rose 5.2% quarter-over-quarter to $128B.

Based on Neuberger Berman Group's 13F filing for Q3 2024, filed 14 Nov 2024.